Foyston, Gordon, & Payne’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-29,260
Closed -$1.58M 64
2022
Q2
$1.58M Sell
29,260
-79,338
-73% -$4.61M 0.46% 50
2022
Q1
$6.24M Buy
108,598
+7,321
+7% +$374K 1.53% 24
2021
Q4
$4.79M Sell
101,277
-35,382
-26% -$1.61M 1.12% 36
2021
Q3
$5.75M Buy
136,659
+17,104
+14% +$740K 1.44% 23
2021
Q2
$5.3M Buy
119,555
+11,272
+10% +$521K 1.26% 27
2021
Q1
$5.05M Sell
108,283
-92,733
-46% -$4.1M 1.19% 29
2020
Q4
$7.78M Sell
201,016
-17,288
-8% -$618K 1.88% 17
2020
Q3
$6.29M Sell
218,304
-95,476
-30% -$2.69M 1.62% 22
2020
Q2
$8.41M Sell
313,780
-173
-0.1% -$4.5K 2.06% 13
2020
Q1
$7.38M Buy
313,953
+3,903
+1% +$107K 1.92% 13
2019
Q4
$9.16M Buy
310,050
+174,542
+129% +$4.62M 1.73% 20
2019
Q3
$3.79M Buy
135,508
+51,273
+61% +$1.48M 0.75% 29
2019
Q2
$2.49M Buy
+84,235
New +$2.27M 0.46% 40

Other funds holding CTVA

Foyston, Gordon, & Payne's CTVA Position: Q3 2022 in Review

Foyston, Gordon, & Payne sold out of Corteva (CTVA) in Q3 2022, closing a stake of 29,260 shares — an estimated $1.58M sold.

Foyston, Gordon, & Payne first reported a position in CTVA in Q2 2019 and held it in 13 quarters. The position peaked at $9.16M in Q4 2019. 1,225 funds tracked by Wall St. Rank hold CTVA as of Q3 2022.

  • Foyston, Gordon, & Payne reported no remaining Corteva position as of Q3 2022 after selling out during the quarter.
  • Foyston, Gordon, & Payne sold 29,260 Corteva shares in Q3 2022, an estimated $1.58M.
  • Foyston, Gordon, & Payne first reported a position in Corteva in Q2 2019 and held it in 13 quarters.
  • Foyston, Gordon, & Payne's Corteva position peaked at $9.16M in Q4 2019.
  • 1,225 funds tracked by Wall St. Rank held Corteva as of Q3 2022.

Based on Foyston, Gordon, & Payne's 13F filing for Q3 2022, filed 4 Nov 2022.